Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells. The gene discussed is TNFRSF9; the disease is head and neck squamous cell carcinoma.